Jeffrey P. Callen, M.D., FACP, FAAD, MACR

• Professor of Medicine
• Chief, Division of Dermatology
• Lafayette G. Owen, M.D. Endowed Chair of Dermatology

3810 Springhurst Blvd.
Louisville, KY 40241

502-322-1954 - Academic Office
502-583-1749 - Patient Appointments

Clinical Expertise
Skin Signs of Systemic Diseases; Lupus Erythematosus; Dermatomyositis; Pyoderma Gangrenosum; Psoriasis; Systemic Therapies for Management of Skin Disease

Featured Publications

• Durbin A, Callen JP, Schadt CR. Proton pump inhibitor-induced subacute cutaneous lupus erythematosus. Dermatol Ther. 2022 Dec;35(12):e15959. doi: 10.1111/dth.15959. Epub 2022 Nov 6. PMID: 36284259.
• Perna DL, Callen JP, Schadt CR. Association of Treatment With Secukinumab With Exacerbation of Dermatomyositis in a Patient With Psoriasis. JAMA Dermatol. 2022 Apr 1;158(4):454-456. doi: 10.1001/jamadermatol.2021.6011. PMID: 35171205.
• Oldroyd AGS, Allard AB, Callen JP, Chinoy H, Chung L, Fiorentino D, George MD, Gordon P, Kolstad K, Kurtzman DJB, Machado PM, McHugh NJ, Postolova A, Selva-O'Callaghan A, Schmidt J, Tansley S, Vleugels RA, Werth VP, Aggarwal R. Corrigendum to: A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Rheumatology (Oxford). 2021 Nov 3;60(11):5483. doi: 10.1093/rheumatology/keab616. Erratum for: Rheumatology (Oxford). 2021 Jun 18;60(6):2615-2628. PMID: 34689208; PMCID: PMC8623712.
• Sheriff S, Callen JP, Schadt CR. Cutaneous Lupus Erythematosus of the Vulvar Skin. JAMA Dermatol. 2021 Nov 1;157(11):1370. doi: 10.1001/jamadermatol.2021.3293. PMID: 34524391.
• Callen JP. Skin Signs of Systemic Diseases. Med Clin North Am. 2021 Jul;105(4):xvii-xviii. doi: 10.1016/j.mcna.2021.04.013. PMID: 34059252.
• Oldroyd AGS, Allard AB, Callen JP, Chinoy H, Chung L, Fiorentino D, George MD, Gordon P, Kolstad K, Kurtzman DJB, Machado PM, McHugh NJ, Postolova A, Selva-O'Callaghan A, Schmidt J, Tansley S, Vleugels RA, Werth VP, Aggarwal R. A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies. Rheumatology (Oxford). 2021 Jun 18;60(6):2615-2628. doi: 10.1093/rheumatology/keab166. Erratum in: Rheumatology (Oxford). 2021 Nov 3;60(11):5483. PMID: 33599244; PMCID: PMC8213426.
• Margheim A, Schadt CR, Callen JP. Multiple drugs as inducing or exacerbating agents in subacute cutaneous lupus erythematosus. Int J Dermatol. 2021 May;60(5):643-644. doi: 10.1111/ijd.15290. Epub 2020 Oct 31. PMID: 33128457.
• Figueredo Zamora E, Callen JP, Schadt CR. Drug-induced subacute cutaneous lupus erythematosus associated with abatacept. Lupus. 2021 Apr;30(4):661-663. doi: 10.1177/0961203320981146. Epub 2020 Dec 22. PMID: 33349110.
• Spaulding RT, Owen CE, Callen JP. New patterns of cutaneous drug eruptions. Clin Dermatol. 2021 Mar-Apr;39(2):233-239. doi: 10.1016/j.clindermatol.2020.10.005. Epub 2020 Oct 30. PMID: 34272016.
• Kwan K, Sears S, Callen J, Rady P, Tyring S, Bahrami S, Huelsman M, Malone J. Keratotic spines in a patient with pruritic and dyskeratotic dermatosis: A new clinical finding. JAAD Case Rep. 2020 Nov 24;7:103-106. doi: 10.1016/j.jdcr.2020.11.015. PMID: 33364280; PMCID: PMC7750708.